These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2860429)

  • 1. HLA DR4 antibodies cause positive HTLV-III antibody ELISA results.
    Kühnl P; Seidl S; Holzberger G
    Lancet; 1985 May; 1(8439):1222-3. PubMed ID: 2860429
    [No Abstract]   [Full Text] [Related]  

  • 2. False-positive anti-HTLV-III assay results and HLA-DR4.
    Kenrick KG; Bolton W; Doran TJ
    Med J Aust; 1985 Jul; 143(2):88-9. PubMed ID: 2991712
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA-DR antibodies and HTLV-III antibody ELISA testing.
    Weiss SH; Mann DL; Murray C; Popovic M
    Lancet; 1985 Jul; 2(8447):157. PubMed ID: 2862348
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA antibodies detected by ELISA HTLV-III antibody kits.
    Hunter JB; Menitove JE
    Lancet; 1985 Aug; 2(8451):397. PubMed ID: 2862557
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell immunoperoxidase method for detecting HTLV-III antibodies.
    Lancet; 1985 Nov; 2(8463):1065-6. PubMed ID: 2865539
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-HTLV-III screening of blood donors.
    Kühnl P; Seidl S; Holzberger G
    Vox Sang; 1986; 51 Suppl 1():15-20. PubMed ID: 3017001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat inactivation of serum may interfere with HTLV-III/LAV serology.
    van den Akker R; Hekker AC; Osterhaus AD
    Lancet; 1985 Sep; 2(8456):672. PubMed ID: 2863663
    [No Abstract]   [Full Text] [Related]  

  • 8. Heat inactivation of serum may interfere with tests for antibodies to LAV/HTLV-III.
    van Beers D; Duys M; Maes M; Biarent D; Haumont D
    J Virol Methods; 1985 Dec; 12(3-4):329. PubMed ID: 3009518
    [No Abstract]   [Full Text] [Related]  

  • 9. [False-positive results in the detection of anti-LAV/HTLV-III antibodies by enzyme immunoassay].
    Näher H; Tilgen W; Tilz G; Petzoldt D
    Hautarzt; 1986 Jun; 37(6):338-40. PubMed ID: 3013804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).
    Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a new assay for antibodies to LAV/HTLV III.
    Maskill W; Healey D; Wootten A; Silvester C; Johnson S; O'Dwyer C; Jacklin R; Pringle R; Gust I; Harden P
    J Virol Methods; 1986 Jul; 13(4):273-8. PubMed ID: 3018016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photometric reading of anti-HTLV-III ELISA kits.
    Grunnet N; Jersild C; Georgsen J
    Lancet; 1985 Dec; 2(8467):1302. PubMed ID: 2866361
    [No Abstract]   [Full Text] [Related]  

  • 13. Serological characterization of HTLV-III infection in AIDS and related disorders.
    Groopman JE; Chen FW; Hope JA; Andrews JM; Swift RL; Benton CV; Sullivan JL; Volberding PA; Sites DP; Landesman S
    J Infect Dis; 1986 Apr; 153(4):736-42. PubMed ID: 3005434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased reactivity to HTLV-I in inflammatory nervous system diseases.
    Lolli F; Fredrikson S; Kam-Hansen S; Link H
    Ann Neurol; 1987 Jul; 22(1):67-71. PubMed ID: 2888429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-III antibody screening of blood bank donors.
    Lancet; 1985 Mar; 1(8427):523-4. PubMed ID: 2857890
    [No Abstract]   [Full Text] [Related]  

  • 16. ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans.
    Biggar RJ; Gigase PL; Melbye M; Kestens L; Sarin PS; Bodner AJ; Demedts P; Stevens WJ; Paluku L; Delacollette C
    Lancet; 1985 Sep; 2(8454):520-3. PubMed ID: 2863543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of immunoperoxidase staining with indirect immunofluorescence, ELISA, and Western blotting assays for detecting anti-HTLV-I antibodies in systemic lupus erythematosus.
    Yamaguchi K; Matutes E; Kiyokawa T; Nishimura Y; Ishii T; Takatsuki K; Catovsky D
    J Clin Pathol; 1988 Jan; 41(1):57-61. PubMed ID: 2830319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of enzyme immunoassay tests for detection of HTLV-III/LAV antibodies.
    Lyons SF; McGillivray GM; Coppin AP; Schoub BD
    S Afr Med J; 1985 Oct; 68(8):575-6. PubMed ID: 2996159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.
    Weiss SH; Goedert JJ; Sarngadharan MG; Bodner AJ; Gallo RC; Blattner WA
    JAMA; 1985 Jan; 253(2):221-5. PubMed ID: 2981369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-I and type-III HTLV antibodies in hospitalized and out-patient Zairians.
    Gazzolo L; Robert-Guroff M; Jennings A; Duc Dodon M; Najberg G; Peti MM; de-Thé G
    Int J Cancer; 1985 Sep; 36(3):373-8. PubMed ID: 2993173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.